Your browser doesn't support javascript.
loading
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer.
Ferrari, Silvia Martina; Elia, Giusy; Ragusa, Francesca; Paparo, Sabrina Rosaria; Mazzi, Valeria; Miccoli, Mario; Galdiero, Maria Rosaria; Varricchi, Gilda; Foddis, Rudy; Guglielmi, Giovanni; Spinelli, Claudio; La Motta, Concettina; Benvenga, Salvatore; Antonelli, Alessandro; Fallahi, Poupak.
Afiliación
  • Ferrari SM; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Elia G; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Ragusa F; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Paparo SR; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mazzi V; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Miccoli M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Galdiero MR; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy; WAO Center of Excellence, Naples, Italy; Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (
  • Varricchi G; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy; WAO Center of Excellence, Naples, Italy; Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (
  • Foddis R; Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Guglielmi G; U.O. Medicina Preventiva Del Lavoro, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Spinelli C; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • La Motta C; Department of Pharmacy, University of Pisa, Pisa, Italy.
  • Benvenga S; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Antonelli A; Master Program on Childhood, Adolescent and Women's Endocrine Health, University of Messina, Messina, Italy.
  • Fallahi P; Interdepartmental Program of Molecular and Clinical Endocrinology and Women's Endocrine Health, Azienda Ospedaliera Universitaria Policlinico 'G. Martino', Messina, Italy.
Expert Opin Investig Drugs ; 30(9): 913-921, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34428101
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Neoplasias de la Tiroides / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Expert Opin Investig Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Neoplasias de la Tiroides / Inhibidores de Proteínas Quinasas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Expert Opin Investig Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Italia